Segment Information - Schedule of Operating Segments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||||
Operating expenses: | ||||||||||
External research and development costs | [1] | $ 55,703 | $ 33,206 | $ 102,090 | $ 61,922 | |||||
General and administrative operations | 17,462 | 10,916 | 34,171 | 20,381 | ||||||
Depreciation expense | 400 | 606 | 65 | |||||||
Provision for income taxes | 72 | 0 | 155 | 0 | ||||||
Consolidated net loss | (121,435) | (65,910) | ||||||||
Reportable Segment | ||||||||||
Operating expenses: | ||||||||||
Research and development personnel-related (excluding equity-based compensation) | [2] | 16,105 | 7,782 | 31,401 | 13,685 | |||||
External-discovery related costs and other | [2] | 5,307 | 2,217 | 9,434 | 4,288 | |||||
General and administrative personnel-related (excluding equity-based compensation) | [2] | 6,395 | 3,099 | 12,102 | 6,632 | |||||
General and administrative operations | [2],[3] | 4,936 | 4,273 | 10,041 | 7,949 | |||||
Equity-based compensation | [2] | 11,344 | 5,698 | 22,470 | 9,884 | |||||
Depreciation expense | [2] | 399 | 36 | 606 | 65 | |||||
Interest income | (7,141) | (10,306) | (14,981) | (16,393) | ||||||
Provision for income taxes | 72 | 0 | 155 | 0 | ||||||
Consolidated net loss | 66,096 | 33,816 | 121,435 | 65,910 | ||||||
Reportable Segment | APG777 | ||||||||||
Operating expenses: | ||||||||||
External research and development costs | [2] | 22,052 | 8,103 | 36,623 | 14,058 | |||||
Reportable Segment | APG990 / APG777 + APG990 | ||||||||||
Operating expenses: | ||||||||||
External research and development costs | [2] | 3,975 | 6,905 | 7,188 | 12,115 | |||||
Reportable Segment | APG333 / APG777 + APG333 | ||||||||||
Operating expenses: | ||||||||||
External research and development costs | [2] | 1,185 | 3,796 | 3,619 | 7,455 | |||||
Reportable Segment | APG808 | ||||||||||
Operating expenses: | ||||||||||
External research and development costs | [2] | $ 1,467 | $ 2,213 | $ 2,777 | $ 6,172 | |||||
|
X | ||||||||||
- Definition External discovery related costs and other. No definition available.
|
X | ||||||||||
- Definition General and administrative personnel related excluding equity based compensation. No definition available.
|
X | ||||||||||
- Definition Research and development personnel related excluding equity based compensation. No definition available.
|
X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|